Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials

Visa sponsorship

  • United States · H-1B filings in 12 months: 2

Visa details by country

Overview

Amplifying Science Leveraging our decades of siRNA drug development experience and proprietary technologies, we are focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Learn more about our next-generation research technologies.

News

Latham & Watkins Advises on ADARx Pharmaceuticals' Upsized US$446.3 Million Initial Public Offering
ADARx Pharmaceuticals, Inc., a late-stage clinical biotechnology company developing next-generation siRNA therapeutics, has announced the pricing...
Read more
Report
News YahooFinance 7 days ago
ADARx Pharmaceuticals (ADRX) Moved Higher, But What Is Drawing Attention?
ADARx Pharmaceuticals (ADRX) has just completed a US$446.25 million IPO at US$17 per share, placing the RNA-focused biotech at roughly US$2.1 billion in market value. The first sessions post listing have been active for ADARx Pharmaceuticals, with the lat
Read more
Report
News YahooFinance 9 days ago
ADARx Pharmaceuticals raises $446 million in upsized IPO
The San Diego RNA drug developer sold 26.3 million shares at $17 apiece, with AbbVie investing up to $100 million in a concurrent private placement
Read more
Report
News BioPharmaDive 11 days ago
RNAi drug specialist ADARx raises $446M IPO
ADARx is the only maker of RNA-based drugs to go public since 2024 and the first RNAi biotech to price an IPO in the U.S. in more than a decade.
Read more
Report
News 24/7 Wall St. 14 days ago
ADARx Pharmaceuticals sets terms for $350 million Nasdaq IPO (ADRX)
ADARx just put a number on its RNAi debut: 21.875 million shares at $15 to $17, or roughly $350 million at the midpoint, with J.P. Morgan and Morgan Stanley leading. That makes it one of the largest…
Read more
Report
Show more news

Tech stack

Technologies named in job postings at ADARx Pharmaceuticals over the last 12 months, by layer, with the share of postings for each.
Technologies in use
1
Postings analysed
2
Stack modernity
43/100
Developer tools
Microsoft Excel
Sign in to see how your skills match this stack Sign In

Salary insights

Compensation ranges based on this company's open jobs
Median
$230k
Typical range
$85k – $325k
Open positions
9
9 Jobs
Senior 44.4%
Staff 11.1%
Architect 44.4%
Level Jobs Median Typical range
Senior 4 $133k $85k – $250k
Staff 1 $95k $95k
Architect 4 $253k $230k – $325k
Highest paying role Executive Director, Chief of Staff $325k
Normalized to USD per year
All salaries at ADARx Pharmaceuticals By role, level and city, against the market · 9 jobs with pay

Growth

Hiring Momentum
33/100
Slowing
Open positions
9
1 opened / 0 closed in 30 days
ATS activity
Every ~3 hours
Today
Hiring Dynamics 0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Finance
38% ▲
Administrative
13% ▲
HR
13% ▲
Legal
13% ▲
Operations
13% ▲
Science & Research
13% ▲
Actively hiring for Finance (+3 in 30 days)

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
San Diego
San Diego United States
Plant / site
Location
9 open roles 8 posted in 90 days 22% engineering 50-200 est. staff $195k Avg Salary
hires for Finance, Science & Research, Administrative
5871 Oberlin Drive, Suite 200, San Diego, CA 92121
seen since Mar 2026 company site, job postings